PEPTIDE CORPUS

Gastrointestinal Health

KPV

Space-filling model of KPV

An anti-inflammatory peptide fragment for mucosal and swelling research.

Last updated

Studied forMucosal inflammation support · IBD symptom research · Post-injury swelling
Evidence on file1 animal study · 1 citation not yet graded
Strongest sourcePepT1-Mediated Tripeptide KPV Uptake Reduces Intestinal Inflammation (Gastroenterology 2008, cited 111x) (animal study)

Mechanism

Alpha-MSH fragment associated with NF-kB down-regulation and mast-cell stabilization.

Reported effects

What sources associate with this compound. Reported categories, not outcomes we have graded — each would need its own citation and rung.

  • Mucosal inflammation support
  • IBD symptom research
  • Post-injury swelling

Dosing on file unverified

200-500 mcg daily, cycled 4–8 weeks

Reported doseVolumeDraw
Low — 200 mcg0.2 mL20 units
High — 500 mcg0.5 mL50 units

What that assumes. Assumes 2 mg in 2 mL (1000 mcg/mL) drawn on a U-100 barrel — the preset on this record, not a recommendation and not the only way to mix it. Change the vial mass, the diluent or the barrel and every number in this table changes. Run your own.

Carried from a source that labels it unverified, and reproduced with that label attached. A record of what is reported, not a recommendation. No citation on this page establishes it.

Reconstitution

VialDiluentConcentrationTypical doseDraw
2 mg2 mL1000 mcg/mL200 mcg20 units

mass ÷ diluent = concentration; dose ÷ concentration = volume; volume × the syringe factor = units on the barrel (100 for U-100, 40 for U-40). Run your own numbers.

Literature on file 2

Not graded

1 citation whose study design could not be read from the title. Left ungraded rather than guessed at.

Identity

PubChem CID 125672 computed 3D conformer Space-filling 3D model of KPV, carbon grey, nitrogen blue, oxygen red
Built from the SMILES on this record — the atoms, bonds and stereochemistry are exact. The shape is one computed low-energy pose, not a measured structure: a flexible peptide in solution has no single conformation. The skeletal formula below claims connectivity and nothing more, which is what we actually know.
Skeletal formulathe canonical depiction
2D chemical structure of KPV

Drawn by PubChem from CID 125672, the identifier on this record.

Molecular weight
402.5
Molecular formula
C16H30N4O4
CAS number
67727-97-3
PubChem CID
125672
InChI key
YSPZCHGIWAQVKQ-AVGNSLFASA-N
Sequence
KPV
SMILES
CC(C)[C@@H](C(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)N
InChI
InChI=1S/C16H30N4O4/c1-10(2)13(16(23)24)19-14(21)12-7-5-9-20(12)15(22)11(18)6-3-4-8-17/h10-13H,3-9,17-18H2,1-2H3,(H,19,21)(H,23,24)/t11-,12-,13-/m0/s1

Classified as

Subcutaneousroute
This is the route the reconstitution arithmetic assumes. Mass divided by diluent volume gives concentration, dose divided by concentration gives volume, and volume in mL multiplied by 100 gives units on a U-100 barrel: 5 mg in 2 mL is 2.5 mg/mL, and 0.25 mg comes out at 0.1 mL, which is 10 units.
Oralroute
Route sets what a milligram means. An oral figure and an injected figure for the same compound are not comparable amounts, and treating one as the other is one of the commonest ways a record gets misread.

Also called

  • KPV
  • KPV (GI)

Notes unverified prose

No human RCTs identified; preclinical only; no FDA approval; No completed human RCTs; No human RCTs

Not on file 0

All 8 tracked fields hold a value on this record: molecular weight and formula, CAS number, PubChem CID, amino-acid sequence, SMILES, InChI and InChI key.

Counted from the record itself, not from what a source said it was missing. 136 of 185 records still have at least one empty.

Share this record

Share card for KPV: structure, evidence rung and sources on file
www.peptidecorpus.com/peptides/kpv